The Body Has Both Opioid AND Anti-Opioid Peptides — A Built-In Balancing Act

The brain produces anti-opioid peptides that naturally counterbalance opioid effects, and these may drive the development of opioid tolerance.

Cesselin, F·Fundamental & clinical pharmacology·1995·Moderate EvidenceReview
RPEP-00317ReviewModerate Evidence1995RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The review synthesizes opioid peptide pharmacology including the novel concept of anti-opioid peptides that counterbalance opioid effects and may drive tolerance.

Key Numbers

How They Did This

Narrative review of published literature on opioid and anti-opioid peptide pharmacology, receptor characterization, and physiological roles.

Why This Research Matters

Understanding both opioid and anti-opioid systems is crucial for developing better pain treatments. Anti-opioid peptides may explain why opioid drugs become less effective over time (tolerance).

The Bigger Picture

Understanding anti-opioid systems could transform pain treatment. If tolerance is driven by anti-opioid peptides, blocking them could maintain opioid drug effectiveness without dose escalation.

What This Study Doesn't Tell Us

Narrative review from 1995. Some concepts have been refined or revised since publication. The epsilon receptor's existence remains debated.

Questions This Raises

  • ?Could anti-opioid peptide blockers prevent opioid tolerance?
  • ?Are anti-opioid systems overactive in chronic pain patients?

Trust & Context

Key Stat:
Built-in counter-system Anti-opioid peptides like NPFF naturally oppose opioid effects and may explain why tolerance develops
Evidence Grade:
Moderate — comprehensive review synthesizing opioid and anti-opioid pharmacology as of 1995.
Study Age:
Published in 1995 (31 years ago). Anti-opioid systems are now recognized as important contributors to tolerance and pain modulation.
Original Title:
Opioid and anti-opioid peptides.
Published In:
Fundamental & clinical pharmacology, 9(5), 409-33 (1995)
Authors:
Cesselin, F
Database ID:
RPEP-00317

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What are anti-opioid peptides?

They are natural peptides the brain produces that counteract opioid effects. When opioid signaling increases, anti-opioid peptides ramp up to maintain balance — like a thermostat. This may be why opioid drugs lose effectiveness over time.

Could blocking anti-opioids prevent tolerance?

Theoretically, yes. If anti-opioid peptides drive tolerance, blocking them could keep opioid pain medications working at the same dose, preventing the dangerous dose escalation that leads to addiction and overdose.

Read More on RethinkPeptides

Cite This Study

RPEP-00317·https://rethinkpeptides.com/research/RPEP-00317

APA

Cesselin, F. (1995). Opioid and anti-opioid peptides.. Fundamental & clinical pharmacology, 9(5), 409-33.

MLA

Cesselin, F. "Opioid and anti-opioid peptides.." Fundamental & clinical pharmacology, 1995.

RethinkPeptides

RethinkPeptides Research Database. "Opioid and anti-opioid peptides." RPEP-00317. Retrieved from https://rethinkpeptides.com/research/cesselin-1995-opioid-and-antiopioid-peptides

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.